The Distinct Functions of Dopaminergic Receptors on Pain Modulation: A Narrative Review
- PMID: 33688340
- PMCID: PMC7920737
- DOI: 10.1155/2021/6682275
The Distinct Functions of Dopaminergic Receptors on Pain Modulation: A Narrative Review
Abstract
Chronic pain is considered an economic burden on society as it often results in disability, job loss, and early retirement. Opioids are the most common analgesics prescribed for the management of moderate to severe pain. However, chronic exposure to these drugs can result in opioid tolerance and opioid-induced hyperalgesia. On pain modulation strategies, exploiting the multitarget drugs with the ability of the superadditive or synergistic interactions attracts more attention. In the present report, we have reviewed the analgesic effects of different dopamine receptors, particularly D1 and D2 receptors, in different regions of the central nervous system, including the spinal cord, striatum, nucleus accumbens (NAc), and periaqueductal gray (PAG). According to the evidence, these regions are not only involved in pain modulation but also express a high density of DA receptors. The findings can be categorized as follows: (1) D2-like receptors may exert a higher analgesic potency, but D1-like receptors act in different manners across several mechanisms in the mentioned regions; (2) in the spinal cord and striatum, antinociception of DA is mainly mediated by D2-like receptors, while in the NAc and PAG, both D1- and D2-like receptors are involved as analgesic targets; and (3) D2-like receptor agonists can act as adjuvants of μ-opioid receptor agonists to potentiate analgesic effects and provide a better approach to pain relief.
Copyright © 2021 Xia-qing Wang et al.
Conflict of interest statement
All authors declare no competing interests.
Similar articles
-
Dopaminergic mechanisms in periaqueductal gray-mediated antinociception.Behav Pharmacol. 2018 Apr;29(2 and 3-Spec Issue):225-233. doi: 10.1097/FBP.0000000000000346. Behav Pharmacol. 2018. PMID: 29035918
-
D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat.Eur J Pharmacol. 2019 Jun 15;853:56-64. doi: 10.1016/j.ejphar.2019.03.020. Epub 2019 Mar 13. Eur J Pharmacol. 2019. PMID: 30876975
-
Pain Inhibits Pain: an Ascending-Descending Pain Modulation Pathway Linking Mesolimbic and Classical Descending Mechanisms.Mol Neurobiol. 2019 Feb;56(2):1000-1013. doi: 10.1007/s12035-018-1116-7. Epub 2018 Jun 1. Mol Neurobiol. 2019. PMID: 29858776
-
Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics.Adv Exp Med Biol. 2017;964:109-132. doi: 10.1007/978-3-319-50174-1_9. Adv Exp Med Biol. 2017. PMID: 28315268 Review.
-
Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics.Int J Mol Sci. 2022 Mar 2;23(5):2766. doi: 10.3390/ijms23052766. Int J Mol Sci. 2022. PMID: 35269909 Free PMC article. Review.
Cited by
-
Sex differences in chronic pain-induced mental disorders: Mechanisms of cerebral circuitry.Front Mol Neurosci. 2023 Feb 20;16:1102808. doi: 10.3389/fnmol.2023.1102808. eCollection 2023. Front Mol Neurosci. 2023. PMID: 36891517 Free PMC article. Review.
-
Disrupted Resting-State Functional Connectivity and Effective Connectivity of the Nucleus Accumbens in Chronic Low Back Pain: A Cross-Sectional Study.J Pain Res. 2024 Jun 17;17:2133-2146. doi: 10.2147/JPR.S455239. eCollection 2024. J Pain Res. 2024. PMID: 38915479 Free PMC article.
-
Dysregulation of dopamine neurotransmission in the nucleus accumbens in immobilization-induced hypersensitivity.Front Pharmacol. 2022 Sep 8;13:988178. doi: 10.3389/fphar.2022.988178. eCollection 2022. Front Pharmacol. 2022. PMID: 36160381 Free PMC article.
-
Honokiol ameliorates reserpine-induced fibromyalgia through antioxidant, anti-inflammatory, neurotrophic, and anti-apoptotic mechanisms.Sci Rep. 2025 Jul 17;15(1):25983. doi: 10.1038/s41598-025-07209-w. Sci Rep. 2025. PMID: 40676048 Free PMC article.
-
Addictive Behavior and Evolutionary Adaptation: Mitigated through Genetic Addiction Risk Severity Early Identification and Awareness Integration Theory.Med Res Arch. 2024 Aug;12(8):10.18103/mra.v12i8.5702. doi: 10.18103/mra.v12i8.5702. Epub 2024 Aug 30. Med Res Arch. 2024. PMID: 39610915
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials